-

Johnson Fistel Investigates Encompass Health Following Reports of Poor Patient Outcomes at Rehab Facilities

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims for investors of Encompass Health Corporation (NYSE: EHC) over possible violations of federal securities laws. Investors may be eligible to recover losses from alleged misrepresentations or omissions by the company and its executives.

Johnson Fistel Investigates Encompass Health Following Reports of Poor Patient Outcomes at Rehab Facilities

Share

What if I purchased Encompass Health securities?

If you suffered losses, you may be eligible to participate in a class action or seek recovery:
https://www.johnsonfistel.com/investigations/encompass-health-corporation/

For more information, contact James Baker at (619) 814-4471, jimb@johnsonfistel.com or fjohnson@johnsonfistel.com.

Background:

On July 15, 2025, The New York Times published an article titled "Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed," reporting that Encompass Health "accounts for about one in seven rehab facilities nationally, but owned 34 of the 41 inpatient rehab facilities that Medicare rated as having statistically significantly worse rates of potentially preventable readmissions for discharged patients" and that Encompass Health "owned 28 of the 87 rehab facilities – 65 of which were for-profit – that had worse rates of potentially preventable readmissions to general hospitals during patient stays." Following this news, the price of Encompass Health stock fell by more than 10%.

About Johnson Fistel, PLLP:

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in securities class actions and shareholder derivative lawsuits, including foreign investors on U.S. exchanges. In 2024, it was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, recovering approximately $90.7 million for clients where it served as lead or co-lead counsel. For more information, visit www.johnsonfistel.com.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq.
(619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Johnson Fistel, PLLP

NYSE:EHC

Release Versions

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq.
(619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, PLLP

Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.What if I purchased Beta Bionics securities?If you purchased Beta Bionics securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation.Or for more informat...

Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of Simulations Plus, Inc. (NASDAQ: SLP) investors concerning whether the Company or certain of its executive officers violated federal securities laws.The Simulations Plus investigation focuses on investor losses following the Company’s revised fiscal 2025 revenue outlook, reported impairment charge, auditor dismissal, and disclosures concerning segment reporting, reporting-unit determinations, and inter...

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches at Lee Enterprises, Inc.

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duty by the Board of Directors of Lee Enterprises, Inc. (NASDAQ: LEE). If you own Lee Enterprises shares, please consider joining our investigation. To participate or learn more, you can click or copy and paste the following link: https://www.johnsonfistel.com/investigations/lee-enterprises-inc/ Shareholders seeking more information may also contact lead analyst Jim Baker (jimb@johns...
Back to Newsroom